Eric Anderson

427 total citations
20 papers, 107 citations indexed

About

Eric Anderson is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Eric Anderson has authored 20 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Eric Anderson's work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Eric Anderson is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Eric Anderson collaborates with scholars based in United States, Singapore and Canada. Eric Anderson's co-authors include Cornelius Dyke, Jerrold H. Levy, David D. Leedahl, Kwang Woo Ahn, Hasan Hashem, Jaap Jan Boelens, Soyoung Kim, Farid Boulad, Allyson Flower and David A. Jacobsohn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The American Journal of Surgery.

In The Last Decade

Eric Anderson

16 papers receiving 102 citations

Peers

Eric Anderson

CCM

HEMAT

GENET

Joana Batista United Kingdom

Kami Pekayvaz Germany

Annamária Cseh Germany

Pável Olivera Spain

Luca Barcella Italy

Vladimir Ivanov Russia

Andreas Ehrlich Germany

Irena Zupan Slovenia

Clara Pecoraro Italy

Linda Köster Netherlands

Joana Batista United Kingdom

Eric Anderson

33 ×0.7

CCM

58 ×1.6

HEMAT

16 ×1.2

9 ×0.8

GENET

6 ×0.6

GENET

Citations per year, relative to Eric Anderson Eric Anderson (= 1×) peers Joana Batista

Countries citing papers authored by Eric Anderson

Since Specialization

Citations

This map shows the geographic impact of Eric Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Anderson more than expected).

Fields of papers citing papers by Eric Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Anderson. The network helps show where Eric Anderson may publish in the future.

Co-authorship network of co-authors of Eric Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Anderson. A scholar is included among the top collaborators of Eric Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Anderson. Eric Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Eric, et al.. (2025). Efficacy and Toxicity of Inotuzumab Ozogamicin for Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients after CD19-Chimeric Antigen Receptor (CAR) T-Cell Therapy. Transplantation and Cellular Therapy. 31(2). S432–S433.

Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2025). Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation and Cellular Therapy. 31(10). 826.e1–826.e10. 1 indexed citations

Davies, Stella M., Adam Lane, Deborah Schiff, et al.. (2025). Abatacept Prevents Severe Acute Graft‐Versus‐Host Disease Without Increasing Graft Failure Risk in Pediatric Bone Marrow Failure Syndromes. Pediatric Blood & Cancer. 72(12). e32085–e32085.

Dvorak, Christopher C., Janel Long-Boyle, Hisham Abdel‐Azim, et al.. (2024). Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19–depleted pediatric haploidentical HCT for hematologic malignancy. Blood Advances. 8(23). 6003–6014. 3 indexed citations

Steinberg, Jeffrey A., Scott Olson, Howaida El‐Said, et al.. (2023). Chronic active Epstein–Barr virus and hydroa vacciniforme‐like lymphoproliferative disorder in a pediatric patient complicated by fatal ruptured cerebral artery aneurysm. SHILAP Revista de lepidopterología. 11(6). e7436–e7436. 1 indexed citations

Dvorak, Christopher C., Janel Long-Boyle, Hisham Abdel‐Azim, et al.. (2023). High Exposure of Rabbit Anti-Thymocyte Globulin (ATG) Is Strongly Associated with Inferior DFS in Pediatric Patients with Malignancy Undergoing Alpha-Beta T-Cell Depleted Haploidentical HCT. Blood. 142(Supplement 1). 3533–3533. 1 indexed citations

Alkhateeb, Hassan B., Victor Aquino, Michelle Hudspeth, et al.. (2022). CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL. Blood. 140(Supplement 1). 12762–12763.

Pulsipher, Michael A., Kwang Woo Ahn, Nancy Bunin, et al.. (2022). KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial. Blood. 140(24). 2556–2572. 12 indexed citations

Wong, Victor, et al.. (2022). Tumor Genomic Profiling and Ex Vivo Drug Sensitivity Testing for Pediatric Leukemia and Lymphoma Patients. The Journal of Pediatric Pharmacology and Therapeutics. 27(2). 123–131. 3 indexed citations

10.

Cancio, Maria, Kyle Hebert, Soyoung Kim, et al.. (2021). Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia. Transplantation and Cellular Therapy. 28(2). 101.e1–101.e6. 12 indexed citations

11.

Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2021). Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplantation and Cellular Therapy. 28(3). 174.e1–174.e5. 3 indexed citations

12.

Abdel‐Azim, Hisham, Christopher C. Dvorak, Nancy Bunin, et al.. (2020). Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Event Free Survival (EFS) Irrespective of Hematopoietic Cell Transplantation (HCT) Conditioning Regimen, Graft Αβ T and B-Cell Depletion or Patient Weight Category in Children with Acute Lymphoblastic Leukemia (ALL). Biology of Blood and Marrow Transplantation. 26(3). S90–S92. 1 indexed citations

13.

Anderson, Eric, et al.. (2020). Irradiation‐free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromes. Pediatric Transplantation. 25(2). e13855–e13855. 2 indexed citations

14.

Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2020). Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease. Blood. 136(Supplement 1). 33–33. 1 indexed citations

15.

Abdel‐Azim, Hisham, Christopher C. Dvorak, Nancy Bunin, et al.. (2019). Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL). Blood. 134(Supplement_1). 4624–4624.

16.

Farnaes, Lauge, David Dimmock, Shimul Chowdhury, et al.. (2019). Diagnosis and treatment of a boy with IPEX syndrome presenting with diabetes in early infancy. SHILAP Revista de lepidopterología. 7(11). 2123–2127. 4 indexed citations

17.

Anderson, Eric, et al.. (2018). Disparities in Cardiovascular Risk Factors in Northern Plains American Indians Undergoing Coronary Artery Bypass Grafting. Health Equity. 2(1). 152–160. 5 indexed citations

18.

Anderson, Eric, et al.. (2015). Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis. The American Journal of Surgery. 210(6). 1095–1103. 27 indexed citations

19.

Anderson, Eric, Cornelius Dyke, & Jerrold H. Levy. (2014). Anticoagulation Strategies for the Management of Postoperative Atrial Fibrillation. Clinics in Laboratory Medicine. 34(3). 537–561. 19 indexed citations

20.

Anderson, Eric, et al.. (2004). Solar panel peak power tracking system.. Digital WPI. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact